Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
Annika Rosengren(Sahlgrenska University Hospital), Salim Yusuf(Population Health Research Institute), Karen Yeates(Queen's University), Romaina Iqbal(Aga Khan University), Rita Yusuf(Independent University), Khalid Yusoff(Universiti Teknologi MARA), Deren Quiang(Nanjing Municipal Center for Disease Control And Prevention), Patricio López‐Jaramillo(Universidad De Santander), Martin McKee(London School of Hygiene & Tropical Medicine), Shrikant I. Bangdiwala(Health Sciences Centre), Viswanathan Mohan(Madras Diabetes Research Foundation), Iolanthé M. Kruger(North-West University), Scott A. Lear(Providence Health Care), Koon Teo(Population Health Research Institute), Khalid F. AlHabib(King Saud University), Ehimario Igumbor(University of the Western Cape), Paul Poirier(Cegep de Sainte Foy), Chuangshi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Philip Joseph(Population Health Research Institute), Kristina Bengtsson Boström(Skaraborg Hospital), Andrew Smyth(Ollscoil na Gaillimhe – University of Galway), Sumathy Rangarajan(McMaster University), Pablo Lamelas(Health Sciences Centre), Manmeet Kaur(Post Graduate Institute of Medical Education and Research), Chinthanie Ramasundarahettige(Health Sciences Centre), Sarojiniamma Srilatha(Health Action by People), Andrzej Szuba(Wroclaw Medical University), Álvaro Avezum(Hospital Alemão Oswaldo Cruz), Jephat Chifamba(University of Zimbabwe), Prem Mony(St.John's Medical College Hospital), Rasha Khatib(Birzeit University), Marjan Walli-Attaei(Health Sciences Centre), Sadi Güleç(Ankara University), Wei Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Rajeev Gupta(Eternal Hospital), Yang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fernando Laņas(Universidad de La Frontera), Noushin Mohammadifard(Isfahan University of Medical Sciences), Andreas Wielgosz(University of Ottawa)
Cited by 642
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
|Circulation|2005|3.2k